Heterocylic antiviral compounds

Details Heterocylic antiviral compounds Heterocylic antiviral compounds

2008-03-28

2009-12-01

Habte, Kahsay T (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S071000

Reexamination Certificate

active

07625891

ABSTRACT:
This invention relates to piperidine derivatives of formula I wherein R1, R2, R3and R4are as defined herein useful in the treatment of a variety of disorders, including those in which the modulation of CCR5 receptors is implicated. Disorders that may be treated or prevented by the present derivatives include HIV and genetically related retroviral infections (and the resulting acquired immune deficiency syndrome, AIDS), rheumatoid arthritis, solid organ transplant reject (graft vs. host disease), asthma and COPD.

REFERENCES:
patent: 3399192 (1968-08-01), Regnier et al.
patent: 6391865 (2002-05-01), Baroudy et al.
patent: 6689765 (2004-02-01), Baroudy et al.
patent: 2003/0069252 (2003-04-01), Baroudy et al.
patent: 2003/0166928 (2003-09-01), Schlienger
patent: 2005/0176703 (2005-08-01), Gabriel
patent: 414422 (1994-04-01), None
patent: 1236726 (2002-04-01), None
patent: WO 97/11940 (1997-04-01), None
patent: WO 00/66558 (2000-11-01), None
patent: WO 00/66559 (2000-11-01), None
patent: WO 01/57044 (2001-08-01), None
patent: WO 02/092604 (2002-11-01), None
patent: WO 03/057698 (2003-07-01), None
patent: WO 03/057698 (2003-07-01), None
patent: WO 2007/085567 (2007-08-01), None
patent: WO 2007/085567 (2007-08-01), None
Caroon, J., et al.; “Synthesis and Antihypertensive Activity of a Series of 8-Substituted 1-Oxa-3,8-diazaspiro [4.5]decan-2-ones1”J. Med. Chem. (1981) vol. 24, pp. 1320-1328.
Clark, R., et al.; “Antihypertensive 9-Substituted 1-Oxa-4.9-diazaspiro[5.5]undecan-3-ones1”J. Med. Chem. (1983) vol. 26, pp. 855-861.
Kazmierski, W., et al.; “Recent Progress in Discovery of Small-Molecule CCR5 Chemokine Receptor Ligands as HIV-1 Inhibitors,”Bioorganic&Medicinal Chemistry(2003) vol. 11, pp. 2663-2676.
Palani, A., et al.; “An Orally Bioavailable Human CCR5 Antagonist for the Treatment of HIV Infection,”J. Medicinal Chemistry(2001), vol. 44:21, pp. 3339-3342.
Smith, P.W., et al., “New Spiropiperidines as Potent and Selective Non-Peptide Tachykinin NK2”J. Med. Chem. (1995) vol. 38, pp. 3772-3779.
Tagat, J., et al.; “Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors,”J. Med. Chem. (2001) vol. 44, pp. 3343-3346.

Affiliated with

Also associated with

Rating

Heterocylic antiviral compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocylic antiviral compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocylic antiviral compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4140544